Medicare Enrolled
Dr. Thomas Lombardo, MD
Cardiovascular Disease · Beaumont, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lombardo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lombardo? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lombardo
Dr. Thomas Lombardo is a cardiovascular disease in Beaumont, TX, with 20 years in practice. Based on federal Medicare data, Dr. Lombardo performed 6,229 Medicare services across 3,825 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lombardo received a total of $12,609 from 32 pharmaceutical and/or device companies across 315 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lombardo is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 10% volume in TX$ $12,609 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,229
Medicare services
Top 10% in TX for cardiovascular disease
3,825
Unique beneficiaries
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~311 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, first 20 min/month | 1,203 | $46 | $154 |
| Office visit, established patient (30-39 min) | 739 | $80 | $175 |
| Chronic care management, additional 20 min/month | 631 | $36 | $116 |
| Electrocardiogram (EKG), 12-lead | 542 | $10 | $45 |
| Echocardiogram, transthoracic | 382 | $123 | $460 |
| Remote pacemaker monitoring, 90 days | 292 | $21 | $75 |
| Office visit, established patient (20-29 min) | 176 | $55 | $120 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 168 | $20 | $50 |
| Ultrasound of both sides of head and neck blood flow | 164 | $121 | $466 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 117 | $27 | $130 |
| Remote pacemaker/defibrillator monitoring, 90 days | 117 | $16 | $70 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 107 | $20 | $63 |
| Hospital follow-up visit, low complexity | 107 | $38 | $100 |
| Programming of dual lead pacemaker system | 90 | $55 | $125 |
| Ultrasound study of arm and leg arteries | 82 | $45 | $206 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 75 | $9 | $50 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 74 | $18 | $64 |
| Initial hospital admission, moderate complexity | 72 | $100 | $250 |
| New patient office visit (45-59 min) | 71 | $113 | $275 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 61 | $7 | $20 |
| Cardiac catheterization | 55 | $191 | $650 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 46 | $134 | $475 |
| Ultrasound of leg arteries or artery grafts | 39 | $156 | $583 |
| Hospital follow-up visit, moderate complexity | 39 | $61 | $180 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 37 | $28 | $75 |
| Blood draw (venipuncture) | 33 | $8 | $25 |
| Blood test panel for electrolytes (sodium potassium, chloride, carbon dioxide) | 31 | $7 | $18 |
| Creatine kinase (cardiac enzyme) level, total | 31 | $6 | $17 |
| Blood creatinine level | 31 | $5 | $13 |
| Urea nitrogen level to assess kidney function, quantitative | 31 | $4 | $10 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 30 | $19 | $70 |
| Coronary stent placement | 29 | $404 | $1,500 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 29 | $4 | $30 |
| Heart rhythm recording of continous external ekg over 8-15 days | 29 | $9 | $40 |
| Ct scan of blood vessels of chest with contrast | 28 | $66 | $175 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 27 | $98 | $408 |
| New patient office visit (30-44 min) | 26 | $70 | $175 |
| Ultrasound of heart, follow-up | 25 | $68 | $210 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 25 | $2 | $57 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 23 | $37 | $507 |
| External shock to heart to regulate heart beat | 22 | $105 | $3,603 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 21 | $89 | $310 |
| Programming of single lead pacemaker system | 20 | $50 | $110 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 20 | $188 | $725 |
| Ct scan of heart structure with contrast | 19 | $65 | $220 |
| Natriuretic peptide (heart and blood vessel protein) level | 19 | $38 | $100 |
| Ultrasound of heart with probe in esophagus, with report | 19 | $83 | $230 |
| Ultrasound of heart blood flow, valves and chambers | 19 | $14 | $40 |
| Ct scan of blood vessels and grafts of heart with contrast | 18 | $89 | $250 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 18 | $170 | $600 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 17 | $19 | $65 |
| Evaluation of heart function using tilt table | 16 | $116 | $400 |
| Programming of multiple lead implantable defibrillator system | 14 | $72 | $200 |
| Ct scan of blood vessels of abdomen and pelvis with contrast | 13 | $82 | $200 |
| EKG interpretation and report | 13 | $6 | $20 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 13 | $64 | $175 |
| Programming of dual lead implantable defibrillator system | 12 | $57 | $165 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 11 | $393 | $1,075 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 11 | $268 | $800 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
20.7% high complexity
7.9% medium
71.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,609
Total received (2018-2024)
Avg $1,801/year across 7 years
Top 27% in TX for cardiovascular disease
32
Companies
315
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,648 (44.8%)
Other
Charitable contributions, space rental, and other categories
$5,583 (44.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,377 (10.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$948
2023$635
2022$6,449
2021$2,195
2020$1,024
2019$652
2018$705
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AngioDynamics, Inc.
$6,883
Edwards Lifesciences Corporation
$936
Boston Scientific Corporation
$875
Abbott Laboratories
$477
BOSTON SCIENTIFIC CORPORATION
$389
Janssen Pharmaceuticals, Inc
$352
ShockWave Medical, Inc
$294
Actelion Pharmaceuticals US, Inc.
$272
ABIOMED
$238
PFIZER INC.
$232
Novartis Pharmaceuticals Corporation
$216
AstraZeneca Pharmaceuticals LP
$209
Medtronic, Inc.
$199
Esperion Therapeutics, Inc.
$175
Amgen Inc.
$143
Merck Sharp & Dohme LLC
$142
SANOFI-AVENTIS U.S. LLC
$113
BIOTRONIK INC.
$92
Medtronic Vascular, Inc.
$88
Inspire Medical Systems, Inc.
$83
Amarin Pharma Inc.
$32
Shockwave Medical, Inc
$24
Lexicon Pharmaceuticals, Inc.
$20
Aziyo Biologics, Inc.
$19
MEDICOMP INC
$17
Tactile Systems Technology Inc
$17
Relypsa, Inc.
$14
iRhythm Technologies, Inc.
$14
Arrow International, Inc.
$12
Regeneron Healthcare Solutions, Inc.
$12
HeartFlow, Inc.
$10
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$8
Top 3 companies account for 69.0% of total payments
Associated products mentioned in payments ›
ACCOLADE SR · Amplia MRI · Attesta · Auryon Laser System 100-120 Vac · Azure · BRILINTA · BodyGuardian · CARDIOMEMS · CHANTIX · Catheter - Turnpike · Claria MRI · Compia MRI · Corlanor · Crome · ECM Patch · ELIQUIS · EMBLEM MRI S-ICD · ENTRESTO · EPIC · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Edwards SAPIEN XT Transcatheter Heart Valve · FARXIGA · Flexitouch Plus · GENERAL - BRADY · GENERAL - TACHY · GENERAL PAIN MANAGEMENT · GENERAL TACHY · GENERAL THERAPIES · General - Brady · General - Therapies · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · HeartWare HVAD · INGEVITY MRI · INSPIRE · Impella · Inpefa · LATITUDE · LATITUDE Communicator Power Supply · LEQVIO · LOKELMA · LUX DX · LUX-DX · LUX-Dx Insertable Cardiac Monitor · LUXDX · LifeVest · MITRACLIP · MULTAQ · Micra · Mitra Clip system · NEXLETOL · NEXLIZET · OPSUMIT · OPSUMIT MACITENTAN · PK Papyrus · PRALUENT · Pouch · RESONATE · Repatha · Reveal LINQ · SAPIEN 3 Ultra RESILIA · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SQ-RX PULSE GENERATOR · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · TELEPATCH CARDIAC MONITOR · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · Tri-Ad · UPTRAVI · VERQUVO · VYNDAMAX · Vascepa · Veltassa · WATCHMAN Access System · XARELTO · ZIO XT Patch · myLUX Patient Kit with mobile device
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (45%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $202 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
17
Per 100K population
6.7
County median income
$59,934
Nearest hospital
CHRISTUS SOUTHEAST TEXAS- ST ELIZABETH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Lombardo is a clinical cardiology specialist, with above-average Medicare volume (top 10% in TX), and mixed engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Lombardo experienced with chronic care management, first 20 min/month?
Based on Medicare claims data, Dr. Lombardo performed 1,203 chronic care management, first 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lombardo receive payments from pharmaceutical companies?
Yes. Dr. Lombardo received a total of $12,609 from 32 companies across 315 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lombardo's costs compare to other cardiovascular diseases in Beaumont?
Dr. Lombardo's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lombardo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Beaumont
Browse cardiovascular diseases in Beaumont ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
AngioDynamics, Inc. Payments to Doctors
See all physicians who received payments from AngioDynamics, Inc..
By company
Edwards Lifesciences Corporation Payments to Doctors
See all physicians who received payments from Edwards Lifesciences Corporation.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology